- Kaiser Permanente names SVP, Fresno service area manager
- Nebraska hospital CEO resigns amid allegations of $38K in improper spending
- Northwell’s direct contracting business wants to ‘link up’ with other health systems
- PDS Health among 1st to deploy Epic-integrated AI platform
- CommonSpirit’s 5 targets for judging payer prior auth reform — and its Humana milestone
- LifeBridge names division president
- Private equity struggles in healthcare amid mounting pressures: 5 notes for dentistry
- Who’s actually winning the fight for ASC ownership?
- Why some ASCs are buying their own anesthesia groups
- Hospital Sisters Health System names chief technology officer
- Top Medicare Advantage plans for member satisfaction in 2026: JD Power
- How a 12-hospital system saved millions with an inventory overhaul
- Corporate medicine is burning out 90% of employed physicians: 10 survey findings
- HCA Florida hospital names assistant CFO
- GE HealthCare taps new CFO
- 6-property outpatient portfolio acquired
- Patients deserve every evidence-based option for mental healthcare
- 10 anesthesia controversies in 2026
- The $314K cost of employing a physician
- Who’s driving physician M&A in 2026? 5 deals to know
- 5 ways insurers are undercutting anesthesia payments: ASA
- Prior GLP-1 use doesn’t affect bariatric surgery results: 6 things to know
- Statement on Regulation Crypto Assets: Fit-for-purpose Exemptions for Crypto Market Innovation
- Filling the Regulatory Tank: Regulation Crypto Assets Proposing Release
- Statement on Regulation Crypto Assets
- Dental therapy program enrollment up 533% in 5 years
- Dental assisting program enrollment down 5.2% in 5 years
- Dental hygiene program enrollment up 15% in 5 years
- Surgery Partners ditches its $200M M&A target in favor of de novo growth: 5 things to know
- The dental specialties DSOs will prioritize next
- Statement on Commencement of Appointment Process for Public Company Accounting Oversight Board Seat
- Dental school enrollment in the 10 states with the most dental shortage areas
- How To Protect Yourself During Wildfire Season
- Ballmer Institute lands $125M to expand child behavioral health training nationwide
- Judge weighs whether man charged with killing dentist can act as own attorney
- FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
- Included Health to offer Carrum specialty care for alternative plan members
- 52 behavioral health executive moves to know
- Hospital performance improves in June, but lags 2025
- University of Toledo gets nearly $2M to support behavioral health workforce
- CTA reporting requirements eliminated for most dental practices: 5 things to know
- National Alliance on Mental Illness names chief medical officer
- Pennsylvania opens 24/7 behavioral health crisis center
- Cyber criminals target DSOs, dental groups: 3 updates
- OpenAI boosts mental health safeguards for teens
- UnitedHealthcare expands behavioral coaching to 13 million members
- Kindergarten Vaccine Exemptions Hit Record High, New CDC Data Shows
- Loneliness Is A Health Crisis, But Doctors Alone Can't Cure It, Analysis Argues
- Ousted OHSU Healthcare CEO files lawsuit alleging wrongful termination, discrimination
- JD Power: Member satisfaction with Medicare Advantage plans continues to slide
- AMA applauds updated CMS prior authorization reporting guidance
- Constipation In Space: A New Study Provides Answers
- Social Media Beauty Trends May Up Teens' Exposure To Hormone-Disrupting Chemicals
- HIPAA-compliant marketing platform Ours Privacy lands $15M amid growing pixel concerns
- Pharma commercialization partner Valeris brings in new strategy chief
- Biokin bispecific ADC iza-bren hits goal in lung cancer trial, boosting case for BMS’ global test
- CSL shares up 17% as immunoglobulin boost points to signs of recovery
- R1 acquiring Humata Health to bolster AI-powered prior authorizations
- Revance hires Janelle Wichmann as chief marketing officer of skincare unit
- CMI adopts orphan drug field with dedicated center of excellence
- Waist Size Is Accurate Way To Gauge Unhealthy Excess Weight, Study Says
- Panel Offers First Guidelines For Using E-Cigarettes To Help Smokers Quit
- Celcuity keeps cool amid questions about Revtorpyk launch timing
- Newsom Promotes Affordable Insulin, But California's Generic Label Off To A Slow Start
- What Geriatric Emergency Departments Do Differently
- Drive for Nuclear Power Boosts Uranium Industry — And Tribal Health Concerns in Southwest
- Rural primary care company Hopscotch clinches $53M to expand beyond NC
- Eurofins expands operations to meet growing high-potency API demand
- 24 new behavioral health projects to know
- Four health systems, including Ochsner and Denver Health, go live with Epic's real-time prior authorization checks
- 8 new psychiatric residency programs to know
- DocGo agrees to acquire virtual care provider Hicuity Health, assumes $52M debt
- Papa, eternalHealth expand partnership around Plus platform
- Happy Health secures $75M to expand AI-powered care in the home starting with sleep apnea
- As healthcare costs weigh on patients, states could play a bigger role, report finds
- Jalapeño Recalls Keep Growing As Salmonella Outbreak Investigation Continues
- Music Streaming Linked To Rise In Traffic Deaths
- EyePoint shares plummet after phase 3 stumble for AMD drug-device combo Duravyu
- Quanovate takes back marketing claims for Mira fertility wand after P&G challenge
- Sanofi to lay off 229 Blueprint Medicines staffers, close Cambridge offices following acquisition
- Whoop expands Advanced Labs to non-members, adds Grail’s multi-cancer detection test to lineup
- Quartz Countertop Workers Are Falling Prey To Lung Disease
- Kaiser Permanente notches 4.6% Q2 operating margin, $5.3B net income
- Epic faces Federal Trade Commission antitrust investigation, Reuters reports
- Innovaccer, Mastek ink strategic partnership to scale agentic AI in healthcare globally
- Sandoz strikes $322M biosimilars deal with Shanghai Henlius
- Argenx heads to FDA with Vyvgart after ph. 3 win in potential blockbuster autoimmune indication
- Many Smokers Unaware Of Heart, Brain Risks Of Smoking
- Tylenol, Other Medications Fuel Spike In Liver Damage Cases, Poison Center Data Says
- AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure
- My Husband Was Kicked Out Of Hospice For Dying Too Slowly
- Tadalafil (Cialis), Used for BPH and ED, Might Increase Glaucoma Risk, Study Says
- Kennedy’s Quiet Hunt for Autism Culprits Stalls as Trump Orders Baseless Changes to Childhood Shots
- Newsom Promotes Affordable Insulin, but California’s Generic Label Off to a Slow Start
- Inside agency view: Real Chemistry’s Frank Mazzola on audience nuance and rewarding creativity
- Abridge expands AI decision support to more clinicians in bid to become healthcare's copilot
- Danish politicians call out Eli Lilly obesity campaign
- Universal Health Services closes $835M Talkspace acquisition
- Gounder Brings Clarity to Egg Freezing, AI Virus Creation, and New Trump Vaccine Order
- States Enact Emergency Orders On Kratom While Awaiting Federal Rules
- Study examines how ICHRA adoption could help stabilize ACA risk pools
- Winter Is Coming: How Vaccines Help Protect Against Respiratory Illness
- Screen Time Is Not All Bad For Kids' Brains
- Processed Foods Linked To Prostate Cancer Risk
- Updated Statement Regarding the Division of Corporation Finance’s Role in the Exchange Act Rule 14a-8 Process
- It's BMS vs. Celgene investors once more after US appeals court revives lawsuit
- Industry Voices—AI should help cancer patients survive the healthcare system
- Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision
- Sleep Disturbances Linked To Genetic Alzheimer's Risk
- Pre-K Sets Kids Up For School Success, Study Says
- Expect Other Seniors To Act Their Age? Then Expect Problems With Your Own Memory, Study Says
- A genomics library for the AI era
- BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
- People With Disabilities Say Medicaid Income Limits Stifle Career Advancement
- Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage
- My Husband Was Kicked Out of Hospice for Dying Too Slowly
- Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve
- Rare Bacteria In Coastal Waters Has Killed 7 This Summer
- It's crunch time for Karyopharm as company faces potential default next month
- Socializing: A Prescription For Healthier Brain Aging
- Taking The Stairs May Lower Your Risk Of Dying From Heart Disease
- AZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says
- How consumerization is reshaping pharma marketing
- Sweet Tooth? It Could Be Shaping Your Decisions, Study Says
- Stressed Parents Turn To Screens For Help, Study Finds
- Gambling Linked To Mental Health Problems Among College Students
- Hospitals Say They Found A Tool To Help Reduce Childbirth Risks: Wristbands
- Listen to the Latest ‘KFF Health News Minute’
- Readers Speak Out on Work Requirements, Federal Data Grab, Opioid Payback Cash
- People With Disabilities Say Medicaid’s Limits on Income Stifle Career Advancement
- FDA Wants More Information From Food Makers On New Food Chemicals
- Aspirin/Omega-3 Combo Matches Antibiotics In Treating Gum Disease, Trial Finds
- Endometriosis Linked To Higher Type 2 Diabetes Risk
- Beyond Compliance: Rethinking No Surprises Act strategy
- Tamiflu Helps Keep Severely Ill Kids Out Of The ICU, Study Finds
- 'Normal' Can Backfire During Doctor/Patient Discussions
- Experimental Pulse Oximeter Accurate Regardless Of Skin Tone, Researchers Say
- Patients Wary Of Governments, Companies Pushing AI As A Rural Healthcare Solution
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
Michigan healthcare freedom community forum
Mental health has more than 493 recent venture-capital startups totaling more than $ 1.1 Billion in funding. The name defines the motive - making money. Bad actors not excluded.
Who needs the health and wealth gospel, when Hollywood is ready to fill the gap?
https://www.nbcnews.com/news/us-news/selena-gomez-mom-accused-fraud-mental-health-startup-rcna592411
Selena Gomez and her mom accused of fraud over their mental health startup
In a new lawsuit, investors say they gave $1.2 million to Wondermind to build out the company’s products and expected Gomez to be involved in marketing.
Marlene Lenthang and Joe Kottke | Aug. 16, 2026
Superstar Selena Gomez and her mother are accused of defrauding investors of their mental health startup, Wondermind, in a federal lawsuit filed Thursday.
Wondermind, which was co-founded by Gomez; her mother, Mandy Teefey; and Daniella Pierson in November 2021, touts mental fitness practices and tools.
The suit accuses Wondermind and its founders of falsely representing the company’s infrastructure, leadership and partnerships to investors and concealing the alleged fraud for more than three years.
The founders told investors they would build a Wondermind app, boasted advertising deals and secured celebrity cover stories, none of which came to fruition, the complaint says.
Investors poured nearly $1.2 million into Wondermind, but the trio falsely represented the company’s plans to make it profitable, the suit says.
It alleges that investors were kept in the dark until two bombshell media reports portrayed Wondermind as a company in utter disarray.
Gomez’s attorney, Mathew Rosengart, said he will file a motion to dismiss the “baseless claims against her.”
“The allegations that Selena Gomez engaged in any way whatsoever in any purported ‘fraud’ or other wrongdoing are completely meritless, both factually and legally,” he said in a statement.
The suit was filed in federal court in Delaware by Wondermind SRS 44 LLC and Bespoke Wondermind SPV I LLC, limited liability companies that invested in the startup.
They accuse the company and the founding trio of securities fraud, common-law fraud and breach of contract and are seeking rescission — meaning a legal cancellation of the investment contract — as well as damages.
In a statement, Pierson says she categorically denies the allegations and “welcomes the opportunity to present concrete documentation and financial records that establish the facts.”
“To be clear, she has never used investor funds for personal expenses. Quite the opposite: Daniella invested her own money into the business and did not draw a salary from the company,” she said in a statement.
Representatives for Wondermind and Teefey did not immediately respond to requests for comment Thursday.
No products, no updates — and no Selena
Investors say in the suit that they believed the money they gave Wondermind would rapidly scale and build a full suite of company products, including an app, a podcast, an editorial publication and other wellness products.
They also believed that the company’s value lay in Gomez’s involvement as a celebrity with a massive, loyal fan base. The suit alleges that Wondermind had indicated that Gomez would be “intimately involved in the Company” as head of marketing and involved in publicity.
But none of those things happened, the suit says.
“Gomez purported to sign a contract obligating her to perform and then ignored it. The partnerships did not exist. The initiatives never materialized. The app was never built,” it says. “And for three years, while the Company quietly collapsed around them, not one of its founders, officers, or directors said a word to the investors whose money was funding the collapse.”
The investors also allege in the suit that the defendants did not provide timely updates about the status of their investments and the company’s operations unless they were pressed.
In the limited updates they did provide, “they both affirmatively misrepresented the status of the Company’s operations and concealed material information about ongoing issues at the Company,” the complaint says.
Media articles allege a company in disarray
Investors were kept in the dark, the suit alleges, for more than three years.Then came an August 2025 Forbes article focused on Pierson with the headline “‘Smoke And Mirrors’: How This Entrepreneur Exaggerated And Self-Promoted Her Way Into Turmoil.”
Pierson was described to investors as a millionaire executive whose past business, the daily newsletter The Newsette, of which she was CEO, generated $40 million a year, the suit says. Investors were also told she had secured partnerships with JPMorgan and Fidelity.
But the Forbes report cast scrutiny and said Pierson exaggerated her readership and the valuation of her newsletter.
The suit says that investors contacted Teefey for an explanation after the article published and that she responded that Pierson had allegedly “misappropriated investor funds — including the Plaintiffs’ funds — to fund her lavish lifestyle,” including her $60,000 monthly rent for her New York City apartment and monthly expenses, before she was ousted from the company in January 2023.
Yet Teefey had never informed investors about the alleged misappropriated funds before the article was published, the suit says.
An article in The Cut published Sept. 3 titled “What Happened at Wondermind?” based on interviews with current and former employees, alleged the company was falling apart.
“The accounts in the Cut article collectively show that, from the outset, Wondermind had no plan for its future — much less a plan for achieving a multi-billion dollar valuation,” the suit says.
That article alleged that Teefey had a long-running substance abuse problem that impeded her capacity to helm the company, that Gomez sought to distance herself from Wondermind “based on a long-running family dispute” with Teefey and that Pierson had been ousted from the company based on a dispute with Teefey, the suit says.
The article, the suit claims, proved that the company was “in a state of financial calamity” and that “there was no legitimate enterprise in the works.”
Two months later, in November, investors sent the defendants a notice of rescission, demanding the return of their funds, according to their suit. The defendants did not respond “in substance” to the notice, the suit says, but “continued to lull and mislead the plaintiffs.”
After the notice of rescission was sent, Teefey allegedly contacted Bespoke’s representatives suggesting that investors should not file a suit, claiming the company had an escrow account to return the investments, this week’s lawsuit says. When Andrew Resnick, part of Bespoke, followed up for details of the account and the return of funds, “Teefey disappeared,” the suit says.
“In short, there was no ‘escrow account’ or a plan to return the Plaintiffs’ investments,” the complaint says.
Misleading updates
The suit details several allegations of investors’ being given updates that ended up being misleading or false.In June 2022, it says, Pierson told the plaintiffs that Wondermind had grown to more than 150,000 subscribers in one month, that she had met with executives at other companies regarding “large advertising deals” and that she anticipated closing “at least $5M in ad revenue this year.” She also said the company had “interest or confirmation for ‘Cover Story’ features from major celebrities including Camila Cabello, Tim Cook, Elton John, Drake, Megan Thee Stallion and more,” the complaint says.
She said the company was starting to build its “online editorial experience” and an ambassador/referral program, the complaint says. She is alleged to have touted that the company had a potential future value of more than $4 billion.
That led the investors to believe the company had the foundation to operationalize, the suit says.
The suit says that from 2022 to 2025, the plaintiffs “proactively” contacted Teefey and Pierson for updates.
“When the Defendants would provide updates — either by email or on a phone call — they concealed the significant operational and financial issues at the Company. Indeed, the Defendants affirmatively misrepresented that the Company was performing well,” the suit says.
Overall, the suit accuses Wondermind and all defendants of securities fraud, alleging they misrepresented the company’s finances, Gomez’s involvement, Pierson’s business background and Teefey’s fitness (as she had never held a similar startup CEO role). They are further accused of common law fraud and equitable fraud.
Pierson in addition is accused in the suit of securities fraud for what it alleges were misstatements to investors, conversion for wrongfully using investment funds and unjust enrichment.
Wondermind is also accused in the suit of breach of contract-use of investor proceeds, rescission-failures to satisfy conditions precedent, and breach of contract-breach of express representations and warranties.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























